Pain Management - Nociceptive Flashcards
WHO Analgesic Ladder
Mild/moderate
-paracetamol
+NSAID
Moderate/severe
-paracetamol
+NSAID
+weak opioid
Severe
-paracetamol
+NSAID
+strong opioid
Paracetamol
- MOA
- SE
- CI, warnings
- max dose
Analgesia - inhibit prostaglandin synth
Antipyretic - acts on hypothalamic temp sensors => peripheral VD
Regular use => decreased opioid use
Starting point for all pain management
ADRs - rare
CI - none
Warnings
-IV dosing based on weight, liver/kidney issues
-care needed when combining with other paracetamol containing products
Max dose - 4g daily in adults
Ibuprofen
- MOA
- SE
- CI, warnings
- max dose
Analgesic and antiinflammatory - inhibit prostaglandin synth (act on COX12)
Suitable for inflammatory, bone, renal colic pain
Regular use => decreased opioid use
GI
-reflux, N+V, gastric ulcers/bleeds, diarrhoea
Renal
-affects kidney function => AKI,CKD, drug metabolism
Resp
-NSAID induced bronchospasm => worsen asthma
CV
-increased risk of thrombotic events in high risk patients
Opioids
- MOA
- SE
- examples of ones used
Analgesia - opioid receptors in CNS => decreased pain perception, reaction and increased tolerance
Weak - used in addition to paracetamol+NSAIDs (dihydrocodiene)
Strong (morphine sulphate) - if weak opioids are insufficient
Regular review of opioids
Common ADRs
- sedation, dizzy
- N+V => antiemetics
- tolerance
- constipation => stimulant laxatives
- itch => antihistamines
ADRs related to high dose changes
- sedation => rep depression
- low HR, RR
When and how to use opioids
Suitable for acute, EoL pain
-not helpful for long term pain
Long term opioid pain relief can be of benefit if dose is low, use is intermittent
Increased risk of harm at PO morphine 120mg/day+ with no increased benefit
Stop opioids if pain remains severe even if no alternatives available
-tapering, stopping high doses needs MDT collaboration
Start low and slowly titrate up
How to choose a suitable NSAID
Chose lowest risk first - ibuprofen (400mg TDS)
Use 1 at a time at BNF doses
Short term use
PPI in
- 65+
- Hx of peptic ulcers/bleeding/performations
- PO CS/AC
- comorbidities
- prolonged use at max dose
Factors affecting choice of opioid
Onset
-rapid onset/slow prolonged effect
Duration
-short/intermediate
Routes of administration
- swallowing?
- patient preference
- IV/SC/IM
Patient choice
- frequency of dosing
- tolerability
Difference between
- tolerance
- dependence
- withdrawal
- pseudoaddiction
- addiction
Tolerance - same dose dose not provide same amount of analgesia
-difficult to differentiate from increased pain
Dependence - body cannot function without analgesia
-dose reduction/withdrawal => withdrawal effects
Withdrawal - symptoms that arise when drug is stopped suddenly/dose tapered too quickly/antagonist given
- SNS response
- increased pain, V+D
Addiction - impaired control, compulsive, continuous use despite harm and craving of a behaviour
Pseudoaddiction - behvaiours that may be mistaken as addiction but are an attempt to obtain better pain relief
- when pain is relieved => behaviours stop
- drug hoarding, attempts to obtain extra supplies, requests for early prescriptions, increased dose
Benefits of multimodal analgesia
Additive and synergistic effects
-opioid sparing
P+O
N+O
N+P